Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Disposition and Metabolism of Radiolabeled Casopitant in Humans

Mario Pellegatti, Ellenia Bordini, Patrizia Fizzotti, Andy Roberts and Brendan M. Johnson
Drug Metabolism and Disposition August 2009, 37 (8) 1635-1645; DOI: https://doi.org/10.1124/dmd.109.026781
Mario Pellegatti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellenia Bordini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrizia Fizzotti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy Roberts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brendan M. Johnson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 37 no. 8 1635-1645
DOI 
https://doi.org/10.1124/dmd.109.026781
PubMed 
19420128

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Accepted May 4, 2009
  • Received January 27, 2009
  • Published online July 17, 2009.

Article Versions

  • Earlier version (May 6, 2009 - 07:55).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Mario Pellegatti,
  2. Ellenia Bordini,
  3. Patrizia Fizzotti,
  4. Andy Roberts and
  5. Brendan M. Johnson
  1. Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research & Development, Verona, Italy (M.P., E.B., P.F.); Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, United Kingdom (A.R.); and Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline Research & Development, Research Triangle Park, North Carolina (B.M.J.)
  1. Address correspondence to:
    Mario Pellegatti, PCD DMPK GlaxoSmithKline, Via Fleming, 4, 37135 Verona, Italy. E-mail: Mario.N.Pellegatti{at}gsk.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to May 2023

AbstractFullPdf
Aug 2017099
Sep 2017051
Oct 2017083
Nov 20170734
Dec 201702322
Jan 201802061
Feb 20184984
Mar 20182926
Apr 20182522
May 20180294
Jun 20180182
Jul 20180164
Aug 20180113
Sep 20180184
Oct 20180254
Nov 20180422
Dec 20183050
Jan 20194211
Feb 20192800
Mar 20192300
Apr 20193208
May 2019900
Jun 2019604
Jul 20191402
Aug 20191501
Oct 20192102
Nov 20192111
Dec 20192115
Jan 20202001
Feb 2020712
Mar 20201821
May 2020801
Jun 2020800
Jul 2020800
Aug 2020501
Sep 20202322
Oct 20201571
Nov 2020520
Dec 20201200
Jan 2021921
Feb 20211433
Mar 20212030
Apr 20211110
May 20212210
Jun 20211833
Jul 20219124
Aug 20215412
Sep 2021310
Oct 2021310
Nov 20212041
Dec 20211531
Jan 20222122
Feb 2022712
Mar 2022920
Apr 20221111
May 20221111
Jun 20221510
Jul 202217112
Aug 20221010
Sep 20221921
Oct 20222724
Nov 202221511
Dec 20221211
Jan 20231810
Feb 20232727
Mar 2023731
Apr 20231934
May 20233324

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (8)
Drug Metabolism and Disposition
Vol. 37, Issue 8
1 Aug 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Disposition and Metabolism of Radiolabeled Casopitant in Humans
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Disposition and Metabolism of Radiolabeled Casopitant in Humans

Mario Pellegatti, Ellenia Bordini, Patrizia Fizzotti, Andy Roberts and Brendan M. Johnson
Drug Metabolism and Disposition August 1, 2009, 37 (8) 1635-1645; DOI: https://doi.org/10.1124/dmd.109.026781

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Disposition and Metabolism of Radiolabeled Casopitant in Humans

Mario Pellegatti, Ellenia Bordini, Patrizia Fizzotti, Andy Roberts and Brendan M. Johnson
Drug Metabolism and Disposition August 1, 2009, 37 (8) 1635-1645; DOI: https://doi.org/10.1124/dmd.109.026781
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Sex- and lifestyle-related factors affect hepatic CYP levels
  • Adipocyte PXR does not play an essential role in obesity.
  • CYP3A-mediated oxidation of DABE and BIBR0951
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics